Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child–Pugh Class B

Atez/Bev therapy demonstrated efficacy and safety in patients with CP-B, especially when hepatic reserve is maintained within mALBI grade 2b.

Authors

Hideki Kobara (ORCID: https://orcid.org/0000-0002-8508-827X)
Tomotake Shirono (ORCID: https://orcid.org/0000-0002-2662-6779)
Yasuto Takeuchi (ORCID: https://orcid.org/0000-0003-3261-0842)
Takafumi Yamamoto (ORCID: https://orcid.org/0000-0002-9904-1894)
Norikazu Tanabe (ORCID: https://orcid.org/0009-0005-9502-8886)
Joji Tani (ORCID: https://orcid.org/0000-0001-8801-2505)
Yuki Kanayama (ORCID: https://orcid.org/0000-0002-8639-5212)
Hisamitsu Miyaaki (ORCID: https://orcid.org/0000-0002-8067-4376)
Takeshi Hatanaka (ORCID: https://orcid.org/0000-0003-3656-285X)
Tetsuji Takayama (ORCID: https://orcid.org/0000-0002-0175-1573)
Takanori Ito (ORCID: https://orcid.org/0000-0001-8199-5705)
Tetsu Tomonari (ORCID: https://orcid.org/0000-0002-8484-9866)
Shigeo Shimose (ORCID: https://orcid.org/0000-0003-2068-8386)
Ryu Sasaki (ORCID: https://orcid.org/0000-0002-0001-7377)
Kyo Sasaki
Motoyuki Otsuka (ORCID: https://orcid.org/0000-0003-2869-2881)
Sohji Nishina (ORCID: https://orcid.org/0009-0002-5803-4986)
Atsushi Naganuma (ORCID: https://orcid.org/0000-0003-0663-0102)
Hiroki Kawashima (ORCID: https://orcid.org/0000-0002-3720-781X)
Issei Saeki (ORCID: https://orcid.org/0000-0001-5885-5042)
Satoshi Miuma (ORCID: https://orcid.org/0000-0003-2639-7299)
Hideki Iwamoto (ORCID: https://orcid.org/0000-0001-5688-1335)
Taro Takami (ORCID: https://orcid.org/0000-0002-6689-4989)
Satoru Kakizaki (ORCID: https://orcid.org/0000-0003-0224-7093)
Takumi Kawaguchi (ORCID: https://orcid.org/0000-0002-7064-4325)